L. Douarin, N. Kalcheim, and C. , The neural crest, 1999.
DOI : 10.1017/CBO9780511897948
URL : https://hal.archives-ouvertes.fr/hal-00115827

R. Bolande, The neurocristopathiesA unifying concept of disease arising in neural crest maldevelopment, Human Pathology, vol.5, issue.4, pp.409-429, 1974.
DOI : 10.1016/S0046-8177(74)80021-3

A. Read and V. Newton, Waardenburg syndrome., Journal of Medical Genetics, vol.34, issue.8, pp.656-65, 1997.
DOI : 10.1136/jmg.34.8.656

J. Amiel and S. Lyonnet, Hirschsprung disease, associated syndromes, and genetics: a review, Journal of Medical Genetics, vol.38, issue.11, pp.729-768, 2001.
DOI : 10.1136/jmg.38.11.729

E. Puffenberger, K. Hosoda, S. Washington, K. Nakao, D. Dewit et al., A missense mutation of the endothelin-B receptor gene in multigenic hirschsprung's disease, Cell, vol.79, issue.7, pp.1257-66, 1994.
DOI : 10.1016/0092-8674(94)90016-7

A. Chakravarti, Endothelin receptor-mediated signaling in hirschsprung disease, Hum Mol Genet, vol.5, pp.303-310, 1996.

P. Edery, T. Attie, J. Amiel, A. Pelet, C. Eng et al., Mutation of the endothelin-3 gene in the Waardenburg-Hirschsprung disease (Shah-Waardenburg syndrome), Nature Genetics, vol.35, issue.4, pp.442-446, 1996.
DOI : 10.1038/368703a0

R. Hofstra, J. Osinga, G. Tan-sindhunata, Y. Wu, E. Kamsteeg et al., A homozygous mutation in the endothelin-3 gene associated with a combined Waardenburg type 2 and Hirschsprung phenotype, 1996.

A. Mccallion and A. Chakravarti, EDNRB/EDN3 and Hirschsprung Disease Type II, Pigment Cell Research, vol.14, issue.3, pp.161-170, 2001.
DOI : 10.1034/j.1600-0749.2001.140305.x

V. Pingault, N. Bondurand, N. Lemort, M. Sancandi, I. Ceccherini et al., A heterozygous endothelin 3 mutation in Waardenburg-Hirschsprung disease: is there a dosage effect of EDN3/EDNRB gene mutations on neurocristopathy phenotypes?, Journal of Medical Genetics, vol.38, issue.3, pp.205-214, 2001.
DOI : 10.1136/jmg.38.3.205

A. Brooks, B. Oostra, and R. Hofstra, Studying the genetics of Hirschsprung's disease: unraveling an oligogenic disorder, Clinical Genetics, vol.124, issue.392, pp.6-14, 2005.
DOI : 10.1111/j.1399-0004.2004.00319.x

V. Pingault, N. Bondurand, K. Kuhlbrodt, D. Goerich, M. Prehu et al., SOX10 mutations in patients with Waardenburg-Hirschsprung disease, Nature Genetics, vol.7, issue.2, pp.171-174, 1998.
DOI : 10.1038/ng0198-60

D. Lang and J. Epstein, Sox10 and Pax3 physically interact to mediate activation of a conserved c-RET enhancer, Human Molecular Genetics, vol.12, issue.8, pp.937-982, 2003.
DOI : 10.1093/hmg/ddg107

N. Morgan, S. Westaway, J. Morton, A. Gregory, P. Gissen et al., PLA2G6, encoding a phospholipase A2, is mutated in neurodegenerative disorders with high brain iron, Nature Genetics, vol.5, issue.7, pp.752-756, 2006.
DOI : 10.1038/ng1826

H. Shahin, T. Walsh, T. Sobe, A. Sa, J. et al., Mutations in a Novel Isoform of TRIOBP That Encodes a Filamentous-Actin Binding Protein Are Responsible for DFNB28 Recessive Nonsyndromic Hearing Loss, The American Journal of Human Genetics, vol.78, issue.1, pp.144-52, 2006.
DOI : 10.1086/499495

A. Lalwani, J. Goldstein, M. Kelley, W. Luxford, C. Castelein et al., Human Nonsyndromic Hereditary Deafness DFNA17 Is Due to a Mutation in Nonmuscle Myosin MYH9, The American Journal of Human Genetics, vol.67, issue.5, pp.1121-1129, 2000.
DOI : 10.1016/S0002-9297(07)62942-5

K. Heath, A. Campos-barros, A. Toren, G. Rozenfeld-granot, L. Carlsson et al., Nonmuscle Myosin Heavy Chain IIA Mutations Define a Spectrum of Autosomal Dominant Macrothrombocytopenias: May-Hegglin Anomaly and Fechtner, Sebastian, Epstein, and Alport-Like Syndromes, The American Journal of Human Genetics, vol.69, issue.5, pp.1033-1078, 2001.
DOI : 10.1086/324267

M. Phelan, R. Rogers, R. Saul, G. Stapleton, K. Sweet et al., 22q13 deletion syndrome, American Journal of Medical Genetics, vol.47, issue.2, pp.91-100, 2001.
DOI : 10.1002/1096-8628(20010615)101:2<91::AID-AJMG1340>3.0.CO;2-C

M. Bonaglia, R. Giorda, E. Mani, G. Aceti, B. Anderlid et al., Identification of a recurrent breakpoint within the SHANK3 gene in the 22q13.3 deletion syndrome, Journal of Medical Genetics, vol.43, issue.10, pp.822-830, 2006.
DOI : 10.1136/jmg.2005.038604

T. Attie, A. Pelet, P. Edery, C. Eng, L. Mulligan et al., proto-oncogene mutations in familial and sporadic Hirschsprung disease, Human Molecular Genetics, vol.4, issue.8, pp.1381-1387, 1995.
DOI : 10.1093/hmg/4.8.1381

L. De-pontual, A. Pelet, M. Clement-ziza, D. Trochet, S. Antonarakis et al., Epistatic interactions with a common hypomorphicRET allele in syndromic Hirschsprung disease, Human Mutation, vol.119, issue.8, pp.790-796, 2007.
DOI : 10.1002/humu.20517

W. Wong, E. Agron, H. Coleman, G. Reed, K. Csaky et al., Genotype-Phenotype Correlation in von Hippel-Lindau Disease With Retinal Angiomatosis, Archives of Ophthalmology, vol.125, issue.2, pp.239-284, 2007.
DOI : 10.1001/archopht.125.2.239

S. Kellerer, S. Schreiner, C. Stolt, S. Scholz, M. Bosl et al., Replacement of the Sox10 transcription factor by Sox8 reveals incomplete functional equivalence, Development, vol.133, issue.15, pp.2875-86, 2006.
DOI : 10.1242/dev.02477